Sign in

CIK 0001175151 · Non-accelerated filer<br>Smaller reporting company

Cytosorbents Corp

Sign in to watch
Ticker
CTSO
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
980373793
Phone
973-329-8885
Business address
305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Former names
MedaSorb Technologies CORP, GILDER ENTERPRISES INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Grant or award President & COO acquired 73,000 shares (grant or award)
  3. 4 Grant or award Chief Medical Officer acquired 55,000 shares (grant or award)
  4. 4 Open-market buy Interim CFO bought 3,300 shares at an average $2.85 ($9,389)
  5. 4 Open-market buy Interim CFO bought 10,000 shares at an average $3.11 ($31,058)
  6. 4 Option exercise See Remarks acquired 10,000 shares (option exercise)
  7. 4 Option exercise Chief Executive Officer acquired 30,500 shares (option exercise)
  8. 4 Gift Director gave 2,000 shares (gift)
  9. 4 Option exercise Director acquired 12,000 shares (option exercise)
  10. 4 Open-market buy Chief Executive Officer bought 5,859 shares at $1.26 ($7,382)
  11. 4 Open-market buy Chief Executive Officer bought 24,141 shares at an average $1.26 ($30,475)
  12. 4 Open-market buy Chief Executive Officer bought 35,000 shares at $1.70 ($59,500)
  13. 4 Open-market buy Director bought 1,000 shares at $1.91 ($1,910)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Grant or award Chief Medical Officer acquired 107,000 shares (grant or award)
  20. 4 Grant or award President and COO acquired 69,000 shares (grant or award)

Page 4 of 20 · 395 filings